{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T12:50:52Z","timestamp":1782478252966,"version":"3.54.5"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Urologie"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s00120-026-02838-z","type":"journal-article","created":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T14:56:33Z","timestamp":1779116193000},"page":"775-783","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Multiresistente Erreger in Klinik und Praxis","Clinical and practical aspects of multidrug-resistant pathogens"],"prefix":"10.1007","volume":"65","author":[{"given":"Fabian P.","family":"Stangl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Kranz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,18]]},"reference":[{"issue":"3","key":"2838_CR1","doi-asserted-by":"publisher","DOI":"10.2174\/1871526523666230725103902","volume":"24","author":"JA Alara","year":"2024","unstructured":"Alara\u00a0JA, Alara\u00a0OR (2024) An Overview of the Global Alarming Increase of Multiple Drug Resistant: A Major Challenge in Clinical Diagnosis. Infect Disord Drug Targets 24(3):e250723219043. https:\/\/doi.org\/10.2174\/1871526523666230725103902","journal-title":"Infect Disord Drug Targets"},{"key":"2838_CR2","unstructured":"O\u2019Neill J (2016) Tackling drug-resistant infections globally: final report and recommendations."},{"issue":"1","key":"2838_CR3","doi-asserted-by":"publisher","first-page":"61","DOI":"10.4111\/icu.2017.58.1.61","volume":"58","author":"J Medina-Polo","year":"2017","unstructured":"Medina-Polo\u00a0J, Sope\u00f1a-Sutil\u00a0R, Ben\u00edtez-Sala\u00a0R et\u00a0al (2017) Prospective study analyzing risk factors and characteristics of healthcare-associated infections in a Urology ward. Investig Clin Urol 58(1):61\u201369. https:\/\/doi.org\/10.4111\/icu.2017.58.1.61","journal-title":"Investig Clin Urol"},{"issue":"12","key":"2838_CR4","doi-asserted-by":"publisher","first-page":"e368","DOI":"10.1016\/s1473-3099(18)30296-2","volume":"18","author":"A Chatterjee","year":"2018","unstructured":"Chatterjee\u00a0A, Modarai\u00a0M, Naylor\u00a0NR et\u00a0al (2018) Quantifying drivers of antibiotic resistance in humans: a systematic review. Lancet Infect Dis 18(12):e368\u2013e378. https:\/\/doi.org\/10.1016\/s1473-3099(18)30296-2","journal-title":"Lancet Infect Dis"},{"issue":"10014","key":"2838_CR5","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/s0140-6736(15)00473-0","volume":"387","author":"AH Holmes","year":"2016","unstructured":"Holmes\u00a0AH, Moore\u00a0LS, Sundsfjord\u00a0A et\u00a0al (2016) Understanding the mechanisms and drivers of antimicrobial resistance. Lancet 387(10014):176\u2013187. https:\/\/doi.org\/10.1016\/s0140-6736(15)00473-0","journal-title":"Lancet"},{"key":"2838_CR6","unstructured":"M G, S P. S3-Leitlinie Antibiotikatherapie schwerer Infektionen mit multiresistenten Bakterien. AWMF Leitlinien Register2025."},{"key":"2838_CR7","doi-asserted-by":"publisher","unstructured":"(2022) Global burden of bacterial antimicrobial resistance in 2019: a\u00a0systematic analysis. Lancet 399(10325):629\u2013655. https:\/\/doi.org\/10.1016\/s0140-6736(21)02724-0","DOI":"10.1016\/s0140-6736(21)02724-0"},{"issue":"1","key":"2838_CR8","doi-asserted-by":"publisher","first-page":"25","DOI":"10.4103\/0974-7796.106962","volume":"5","author":"S Picozzi","year":"2013","unstructured":"Picozzi\u00a0S, Ricci\u00a0C, Gaeta\u00a0M et\u00a0al (2013) Do we really know the prevalence of multi-drug resistant Escherichia coli in the territorial and nosocomial population? Urol Ann 5(1):25\u201329. https:\/\/doi.org\/10.4103\/0974-7796.106962","journal-title":"Urol Ann"},{"issue":"5","key":"2838_CR9","doi-asserted-by":"publisher","first-page":"e103","DOI":"10.1093\/cid\/ciq257","volume":"52","author":"K Gupta","year":"2011","unstructured":"Gupta\u00a0K, Hooton\u00a0TM, Naber\u00a0KG et\u00a0al (2011) International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A\u00a02010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis 52(5):e103\u2013e120. https:\/\/doi.org\/10.1093\/cid\/ciq257","journal-title":"Clin Infect Dis"},{"issue":"9","key":"2838_CR10","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1093\/jac\/dks214","volume":"67","author":"AK van der Bij","year":"2012","unstructured":"van der Bij\u00a0AK, Pitout\u00a0JD (2012) The role of international travel in the worldwide spread of multiresistant Enterobacteriaceae. J\u00a0Antimicrob Chemother 67(9):2090\u20132100. https:\/\/doi.org\/10.1093\/jac\/dks214","journal-title":"J Antimicrob Chemother"},{"issue":"8","key":"2838_CR11","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1093\/cid\/cix893","volume":"66","author":"RA Bonomo","year":"2018","unstructured":"Bonomo\u00a0RA, Burd\u00a0EM, Conly\u00a0J et\u00a0al (2018) Carbapenemase-Producing Organisms: A Global Scourge. Clin Infect Dis 66(8):1290\u20131297. https:\/\/doi.org\/10.1093\/cid\/cix893","journal-title":"Clin Infect Dis"},{"issue":"2","key":"2838_CR12","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1093\/jac\/dkl483","volume":"59","author":"DM Livermore","year":"2007","unstructured":"Livermore\u00a0DM, Canton\u00a0R, Gniadkowski\u00a0M et\u00a0al (2007) CTX-M: changing the face of ESBLs in Europe. J\u00a0Antimicrob Chemother 59(2):165\u2013174. https:\/\/doi.org\/10.1093\/jac\/dkl483","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"2838_CR13","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.idc.2016.07.009","volume":"30","author":"K Reyes","year":"2016","unstructured":"Reyes\u00a0K, Bardossy\u00a0AC, Zervos\u00a0M (2016) Vancomycin-Resistant Enterococci: Epidemiology, Infection Prevention, and Control. Infect Dis Clin North Am 30(4):953\u2013965. https:\/\/doi.org\/10.1016\/j.idc.2016.07.009","journal-title":"Infect Dis Clin North Am"},{"issue":"4","key":"2838_CR14","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/nrmicro2761","volume":"10","author":"CA Arias","year":"2012","unstructured":"Arias\u00a0CA, Murray\u00a0BE (2012) The rise of the Enterococcus: beyond vancomycin resistance. Nat Rev Microbiol 10(4):266\u2013278. https:\/\/doi.org\/10.1038\/nrmicro2761","journal-title":"Nat Rev Microbiol"},{"issue":"5","key":"2838_CR15","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/s1473-3099(01)00145-1","volume":"1","author":"MJ Bonten","year":"2001","unstructured":"Bonten\u00a0MJ, Willems\u00a0R, Weinstein\u00a0RA (2001) Vancomycin-resistant enterococci: why are they here, and where do they come from? Lancet Infect Dis 1(5):314\u2013325. https:\/\/doi.org\/10.1016\/s1473-3099(01)00145-1","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"2838_CR16","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.ijantimicag.2011.12.012","volume":"39","author":"DM Livermore","year":"2012","unstructured":"Livermore\u00a0DM (2012) Fourteen years in resistance. Int J Antimicrob Agents 39(4):283\u2013294. https:\/\/doi.org\/10.1016\/j.ijantimicag.2011.12.012","journal-title":"Int J Antimicrob Agents"},{"issue":"2","key":"2838_CR17","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.idc.2016.02.004","volume":"30","author":"D van Duin","year":"2016","unstructured":"van Duin\u00a0D, Paterson\u00a0DL (2016) Multidrug-Resistant Bacteria in the Community: Trends and Lessons Learned. Infect Dis Clin North Am 30(2):377\u2013390. https:\/\/doi.org\/10.1016\/j.idc.2016.02.004","journal-title":"Infect Dis Clin North Am"},{"issue":"5","key":"2838_CR18","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/nrmicro3432","volume":"13","author":"AL Flores-Mireles","year":"2015","unstructured":"Flores-Mireles\u00a0AL, Walker\u00a0JN, Caparon\u00a0M, Hultgren\u00a0SJ (2015) Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol 13(5):269\u2013284. https:\/\/doi.org\/10.1038\/nrmicro3432","journal-title":"Nat Rev Microbiol"},{"issue":"sup1","key":"2838_CR19","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1080\/1120009x.2017.1380395","volume":"29","author":"A Mazzariol","year":"2017","unstructured":"Mazzariol\u00a0A, Bazaj\u00a0A, Cornaglia\u00a0G (2017) Multi-drug-resistant Gram-negative bacteria causing urinary tract infections: a review. J\u00a0Chemother 29(sup1):2\u20139. https:\/\/doi.org\/10.1080\/1120009x.2017.1380395","journal-title":"J Chemother"},{"key":"2838_CR20","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.es.2022.27.30.2101012","author":"J Salm","year":"2022","unstructured":"Salm\u00a0J, Salm\u00a0F, Arendarski\u00a0P, Kramer\u00a0TS (2022) High antimicrobial resistance in urinary tract infections in male outpatients in routine laboratory data, Germany, 2015 to 2020. Euro Surveill. https:\/\/doi.org\/10.2807\/1560-7917.es.2022.27.30.2101012","journal-title":"Euro Surveill"},{"key":"2838_CR21","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.es.2023.28.1.2200850","author":"T Schultze","year":"2023","unstructured":"Schultze\u00a0T, Hogardt\u00a0M, Vel\u00e1zquez\u00a0ES et\u00a0al (2023) Molecular surveillance of multidrug-resistant Gram-negative bacteria in Ukrainian patients, Germany, March to June 2022. Euro Surveill. https:\/\/doi.org\/10.2807\/1560-7917.es.2023.28.1.2200850","journal-title":"Euro Surveill"},{"key":"2838_CR22","doi-asserted-by":"crossref","unstructured":"Chukwudile B, Pan D, Silva L, et\u00a0al. Antimicrobial resistance among migrants in Europe: a\u00a0systematic review and meta-analysis\u2013update from 2017 to 2023. EClinicalMedicine. 2024;75","DOI":"10.1016\/j.eclinm.2024.102801"},{"issue":"39","key":"2838_CR23","doi-asserted-by":"publisher","first-page":"10467","DOI":"10.1073\/pnas.1710235114","volume":"114","author":"J Wang","year":"2017","unstructured":"Wang\u00a0J, Foxman\u00a0B, Mody\u00a0L, Snitkin\u00a0ES (2017) Network of microbial and antibiotic interactions drive colonization and infection with multidrug-resistant organisms. Proc Natl Acad Sci U S\u00a0A 114(39):10467\u201310472. https:\/\/doi.org\/10.1073\/pnas.1710235114","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"2838_CR24","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1017\/ice.2017.34","volume":"38","author":"SL Barnes","year":"2017","unstructured":"Barnes\u00a0SL, Rock\u00a0C, Harris\u00a0AD, Cosgrove\u00a0SE, Morgan\u00a0DJ, Thom\u00a0KA (2017) The Impact of Reducing Antibiotics on the Transmission of Multidrug-Resistant Organisms. Infect Control Hosp Epidemiol 38(6):663\u2013669. https:\/\/doi.org\/10.1017\/ice.2017.34","journal-title":"Infect Control Hosp Epidemiol"},{"key":"2838_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.iccn.2024.103760","volume":"86","author":"Y Garcia-Parejo","year":"2025","unstructured":"Garcia-Parejo\u00a0Y, Gonzalez-Rubio\u00a0J, Garcia Guerrero\u00a0J, Gomez-Juarez Sango\u00a0A, Cantero Escribano\u00a0JM, Najera\u00a0A (2025) Risk factors for colonisation by Multidrug-Resistant bacteria in critical care units. Intensive Crit Care Nurs 86:103760. https:\/\/doi.org\/10.1016\/j.iccn.2024.103760","journal-title":"Intensive Crit Care Nurs"},{"issue":"2","key":"2838_CR26","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.jhin.2018.07.027","volume":"102","author":"KE Gibson","year":"2019","unstructured":"Gibson\u00a0KE, Neill\u00a0S, Tuma\u00a0E, Meddings\u00a0J, Mody\u00a0L (2019) Indwelling urethral versus suprapubic catheters in nursing home residents: determining the safest option for long-term use. J\u00a0Hosp Infect 102(2):219\u2013225. https:\/\/doi.org\/10.1016\/j.jhin.2018.07.027","journal-title":"J Hosp Infect"},{"issue":"4","key":"2838_CR27","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.idc.2018.07.002","volume":"32","author":"EK Shuman","year":"2018","unstructured":"Shuman\u00a0EK, Chenoweth\u00a0CE (2018) Urinary Catheter-Associated Infections. Infect Dis Clin North Am 32(4):885\u2013897. https:\/\/doi.org\/10.1016\/j.idc.2018.07.002","journal-title":"Infect Dis Clin North Am"},{"issue":"1","key":"2838_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-023-08475-7","volume":"23","author":"V Neumeier","year":"2023","unstructured":"Neumeier\u00a0V, Stangl\u00a0FP, Borer\u00a0J et\u00a0al (2023) Indwelling catheter vs intermittent catheterization: is there a\u00a0difference in UTI susceptibility? BMC Infect Dis 23(1):507. https:\/\/doi.org\/10.1186\/s12879-023-08475-7","journal-title":"BMC Infect Dis"},{"issue":"9","key":"2838_CR29","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.32679","volume":"5","author":"A Paumier","year":"2022","unstructured":"Paumier\u00a0A, Asquier-Khati\u00a0A, Thibaut\u00a0S et\u00a0al (2022) Assessment of Factors Associated With Community-Acquired Extended-Spectrum \u03b2\u2011Lactamase-Producing Escherichia coli Urinary Tract Infections in France. JAMA Netw Open 5(9):e2232679. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.32679","journal-title":"JAMA Netw Open"},{"key":"2838_CR30","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.jgar.2020.10.020","volume":"23","author":"IA Critchley","year":"2020","unstructured":"Critchley\u00a0IA, Cotroneo\u00a0N, Pucci\u00a0MJ, Jain\u00a0A, Mendes\u00a0RE (2020) Resistance among urinary tract pathogens collected in Europe during 2018. J\u00a0Glob Antimicrob Resist 23:439\u2013444. https:\/\/doi.org\/10.1016\/j.jgar.2020.10.020","journal-title":"J Glob Antimicrob Resist"},{"key":"2838_CR31","doi-asserted-by":"publisher","DOI":"10.5534\/wjmh.250073","author":"M Chapuis","year":"2026","unstructured":"Chapuis\u00a0M, Kutchukian\u00a0S, Bigot\u00a0P et\u00a0al (2026) Assessment of Infectious Risk Factors in Benign Prostatic Hyperplasia Surgery: Results of the French Multicenter TOCUS Study. World J Mens Health. https:\/\/doi.org\/10.5534\/wjmh.250073","journal-title":"World J Mens Health"},{"issue":"1","key":"2838_CR32","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-024-04853-1","volume":"42","author":"E Ayoub","year":"2024","unstructured":"Ayoub\u00a0E, Kutchukian\u00a0S, Bigot\u00a0P et\u00a0al (2024) Asymptomatic bacteriuria prior to partial and radical nephrectomy: To screen or not to screen? Results from the national and multicenter TOCUS database. World J Urol 42(1):179. https:\/\/doi.org\/10.1007\/s00345-024-04853-1","journal-title":"World J Urol"},{"issue":"3","key":"2838_CR33","doi-asserted-by":"publisher","first-page":"365","DOI":"10.23736\/s2724-6051.24.05725-2","volume":"77","author":"H Robin","year":"2025","unstructured":"Robin\u00a0H, Kutchukian\u00a0S, Bigot\u00a0P et\u00a0al (2025) Impact of antibiotic treatment duration for preoperative asymptomatic bacteriuria, during urological surgery, on postoperative infectious complications: results from the multicentric TOCUS cohort. Minerva Urol Nephrol 77(3):365\u2013374. https:\/\/doi.org\/10.23736\/s2724-6051.24.05725-2","journal-title":"Minerva Urol Nephrol"},{"key":"2838_CR34","doi-asserted-by":"crossref","unstructured":"Bonkat G, Wagenlehner F, Cai T, et\u00a0al. Classification of Urinary Tract Infections in 2025: Moving Beyond Uncomplicated and Complicated. Eur Urol Open Sci. 2025:44\u201347.","DOI":"10.1016\/j.euros.2025.03.010"},{"issue":"Suppl 1","key":"2838_CR35","doi-asserted-by":"publisher","first-page":"i40","DOI":"10.1093\/jac\/dkaa496","volume":"76","author":"E Temkin","year":"2021","unstructured":"Temkin\u00a0E, Margalit\u00a0I, Nutman\u00a0A, Carmeli\u00a0Y (2021) Surgical antibiotic prophylaxis in patients colonized with multidrug-resistant Gram-negative bacteria: practical and conceptual aspects. J\u00a0Antimicrob Chemother 76(Suppl 1):i40\u2013i46. https:\/\/doi.org\/10.1093\/jac\/dkaa496","journal-title":"J Antimicrob Chemother"},{"key":"2838_CR36","doi-asserted-by":"crossref","unstructured":"Stangl FP, Day E, Vall\u00e9e M, et\u00a0al. Infectious Complications After Transrectal Versus Transperineal Prostate Biopsy: A\u00a0Systematic Review and Meta-analysis. Eur Urol Focus. Aug 6 2025;https:\/\/doi.org\/10.1016\/j.euf.2025.07.005","DOI":"10.1016\/j.euf.2025.07.005"}],"container-title":["Die Urologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-026-02838-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00120-026-02838-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-026-02838-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T12:34:49Z","timestamp":1782477289000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00120-026-02838-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,18]]},"references-count":36,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["2838"],"URL":"https:\/\/doi.org\/10.1007\/s00120-026-02838-z","relation":{},"ISSN":["2731-7064","2731-7072"],"issn-type":[{"value":"2731-7064","type":"print"},{"value":"2731-7072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,18]]},"assertion":[{"value":"15 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Gem\u00e4\u00df den Richtlinien des Springer Medizin Verlags werden Autorinnen und Autoren sowie die Wissenschaftliche Leitung im Rahmen der Manuskripterstellung und Manuskriptfreigabe aufgefordert, eine vollst\u00e4ndige Erkl\u00e4rung zu ihren finanziellen und nichtfinanziellen Interessen abzugeben.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F.\u00a0von\u00a0M\u00fcller\u00a0Stangl\n                      : A. Finanzielle Interessen: Repha Pharm IIT Grant. \u2013 Kongressgeb\u00fchren: Janssen, Bayer, OM Pharma. \u2013 B. Nichtfinanzielle Interessen: Gesch\u00e4ftsf\u00fchrender OA Uniklinikum W\u00fcrzburg | EAU YUO Board Member, ESIU Board Member, EAU ID Guidelines Associate Member.\n                      J.\u00a0Kranz\n                      : A. Finanzielle Interessen: Vortragst\u00e4tigkeit: Apogepha, Bionorica SE, Dr. Pfleger, Eumedica, GSK, Johnson&Johnson, medac GmbH, MIP Pharma, MSD, OM-Pharma, Photocure, Repha GmbH, Sysmex. \u2013 Bezahlte Beratungsleistungen, interne Schulungsvortr\u00e4ge, Gehaltsbezug o.\u00e4.: Bionorica SE, Dr. Pfleger, Eumedica, GSK, Johnson&Johnson, medac GmbH, OM-Pharma, Repha GmbH, Shionogi, Sysmex. \u2013 B. Nichtfinanzielle Interessen: Stellvertretende Klinikdirektorin der Klinik f\u00fcr Urologie und Kinderurologie der Uniklinik RWTH Aachen | Vorsitzende der EAU Guidelines on Urological Infections; Mitglied der Steuerungsgruppe der AWMF S3 Leitlinie zu unkomplizierten und komplizierten Harnwegsinfektionen, Stellvertretende Vorsitzende des Arbeitskreises \u201eInfektiologie und Hygiene\u201c der Deutschen Gesellschaft f\u00fcr Urologie e.V. | Mitgliedschaften: ESIU, EAU.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Autorinnen und Autoren"}},{"value":"Die vollst\u00e4ndige Erkl\u00e4rung zum Interessenkonflikt der Wissenschaftlichen Leitung finden Sie am Kurs der zertifizierten Fortbildung auf\n                      \n                      .","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Wissenschaftliche Leitung"}},{"value":"erkl\u00e4rt, dass f\u00fcr die Publikation dieser CME-Fortbildung keine Sponsorengelder an den Verlag flie\u00dfen.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}}]}}